{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:44:08Z","timestamp":1774788248667,"version":"3.50.1"},"reference-count":33,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2016,9,27]]},"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal haematopoietic stem cell disorders characterised by inefficient haematopoiesis and risk of progression to acute myeloid leukaemia. Metaphase cytogenetics is an extremely valuable clinical tool in the management of haematological malignancies. However, metaphase cytogenetics requires cellular proliferation, its sensitivity and resolution depends on the proportion of clonal cells in the sample and size of the lesion, respectively. Single-nucleotide polymorphism array (SNP-A) does not depend on the presence of dividing cells, is able to detect copy number variations with a high resolution and to detect copy number neutral loss of heterozygosity or uniparental disomy (UPD). The aim of this study was to illustrate that the use of SNP-A can cover cryptic chromosomal lesions not identified by metaphase cytogenetics in patients with MDS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Metaphase cytogenetics was performed on bone marrow aspirate using standard methods. Genomic DNA from total bone marrow cells were submitted to SNP-A using Affymetrix Genome-Wide Human SNP CytoScan HD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In our cohort of 15 patients with a diagnosis of MDS and related diseases, chromosomal abnormalities were found in 47% of the cases by SNP-A and in 33% by metaphase cytogenetics. SNP-A detected all lesions identified by metaphase cytogenetics, except a balanced translocation and a marker chromosome. Notably, SNP-A detected a total of 30 new lesions: 1 (3%) gain, 17 (57%) losses and 12 (40%) UPDs in 5 patients with MDS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>SNP-A may complement metaphase cytogenetics to improve the detection of chromosomal abnormalities in myeloid neoplasms.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jclinpath-2016-204023","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T04:28:35Z","timestamp":1478924915000},"page":"435-442","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome"],"prefix":"10.1136","volume":"70","author":[{"given":"Fernanda Borges","family":"da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Agostinho","family":"Machado-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia Helena Leira Lipoli","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira Deolinda Rodrigues Pereira","family":"Velloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Alonso","family":"Ratis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo T","family":"Calado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda Pinto","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Magalh\u00e3es","family":"Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Traina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,11,11]]},"reference":[{"key":"2024053001081066000_70.5.435.1","unstructured":"Swerdlow SH , Campo E , Harris NL , et al . WHO Classification of tumours of haematopoietic and lymphoid tissues. 4th edn. Lyon: IARC, 2008."},{"key":"2024053001081066000_70.5.435.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"2024053001081066000_70.5.435.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-082404"},{"key":"2024053001081066000_70.5.435.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.1175"},{"key":"2024053001081066000_70.5.435.5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/gcc.22112","article-title":"Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing","volume":"52","author":"Arenillas","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"2024053001081066000_70.5.435.6","doi-asserted-by":"publisher","DOI":"10.1007\/BF01700373"},{"key":"2024053001081066000_70.5.435.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-295857"},{"key":"2024053001081066000_70.5.435.8","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"2024053001081066000_70.5.435.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489"},{"key":"2024053001081066000_70.5.435.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07757.x"},{"key":"2024053001081066000_70.5.435.11","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-011-0081-2"},{"key":"2024053001081066000_70.5.435.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.08.023"},{"key":"2024053001081066000_70.5.435.13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.leukres.2016.01.009","article-title":"Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes","volume":"42","author":"Svobodova","year":"2016","journal-title":"Leuk Res"},{"key":"2024053001081066000_70.5.435.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2009.01.005"},{"key":"2024053001081066000_70.5.435.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"2024053001081066000_70.5.435.16","unstructured":"Shaffer LG , McGowan-Jordan J , Schmid M . ISCN (2013): an international system for human cytogenetic nomenclature. Basel: S Karger, 2013."},{"key":"2024053001081066000_70.5.435.17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.6394"},{"key":"2024053001081066000_70.5.435.18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.21.9840"},{"key":"2024053001081066000_70.5.435.19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-079673"},{"key":"2024053001081066000_70.5.435.20","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/modpathol.2016.104","article-title":"Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance","volume":"29","author":"Evans","year":"2016","journal-title":"Mod Pathol"},{"key":"2024053001081066000_70.5.435.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-092304"},{"key":"2024053001081066000_70.5.435.22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-205690"},{"key":"2024053001081066000_70.5.435.23","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.249"},{"key":"2024053001081066000_70.5.435.24","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.167"},{"key":"2024053001081066000_70.5.435.25","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/leu.2016.138","article-title":"Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes","volume":"30","author":"Nazha","year":"2016","journal-title":"Leukemia"},{"key":"2024053001081066000_70.5.435.26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-201848"},{"key":"2024053001081066000_70.5.435.27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-130435"},{"key":"2024053001081066000_70.5.435.28","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2011.11.010"},{"key":"2024053001081066000_70.5.435.29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/gim.2013.49","article-title":"American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders","volume":"15","author":"Cooley","year":"2013","journal-title":"Genet Med"},{"key":"2024053001081066000_70.5.435.30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-631747"},{"key":"2024053001081066000_70.5.435.31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262"},{"key":"2024053001081066000_70.5.435.32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00043426-199605000-00013","article-title":"Transient 7q- in association with megaloblastic anemia due to dietary folate and vitamin B12 deficiency","volume":"18","author":"Wollman","year":"1996","journal-title":"J Pediatr Hematol Oncol"},{"key":"2024053001081066000_70.5.435.33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0165-4608(00)00253-3","article-title":"Trisomy 15 is frequently observed as a minor clone in patients with Anemia\/MDS\/NHL and as a major clone in patients with AML","volume":"121","author":"Batanian","year":"2000","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2016-204023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T15:17:26Z","timestamp":1717082246000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2016-204023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,11]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,4,18]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1136\/jclinpath-2016-204023"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2016-204023","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,11]]}}}